Metoclopramide , commonly used for nausea and digestive issues, crosses into the brain and blocks dopamine receptors
Regular follow-up visits allow us to celebrate your successes, address challenges, and make adjustments when needed to keep you moving toward your goals
Both tirzepatide and semaglutide are FDA-approved, have support from more long-term data, and are already used in real-life settings
By mimicking native fullness hormones at a stronger clinical volume, it slows down the rate at which food leaves your stomach
This concentration is precise and consistent across every lot, ensuring your peptide research remains stable for the full 28-day window
Increases adiponectin secretion by 35 to 50%, improving insulin sensitivity and reducing inflammation Promotes lipolysis (fat breakdown) in a glucose-dependent manner, potentially overcoming the impaired lipolysis seen in lipedema fat Reduces pro-inflammatory adipokine production, including IL-6 and MCP-1 Enhances fatty acid oxidation in white adipose tissue, shifting the metabolic profile from storage to use These effects are distinct from and additive to the GLP-1 receptor-mediated appetite suppression and metabolic improvements
